Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership

 
 
NeuroDerm Ltd. (NDRM) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $18.52 Metrics
OS:
Market cap:
Net cash:
EV:

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)
Date FiledTypeDescription
02/14/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
10/30/2017 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
10/23/2017 EFFECT Form EFFECT - Notice of Effectiveness:
10/18/2017 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
10/18/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/18/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/18/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:


Financial Summary   (All financials)
In millions, except per share itemsDec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12
Revenues27.013.79.03.42.4
            Revenue growth96.9%52.5%162.5%43.0% 
Cost of goods sold-39.2-22.2-17.8-3.1-3.2
Gross profit66.235.926.86.55.6
            Gross margin245.1%262.0%297.6%189.5%234.1%
Research and development27.012.88.12.62.4
General and administrative6.15.25.30.60.4
EBIT33.118.013.43.22.8
            EBIT margin122.5%131.0%148.8%94.7%117.0%
Pre-tax income0.00.00.00.00.0
Income taxes0.00.00.00.00.0
Net income0.00.00.00.00.0
            Net margin0.0%0.0%0.0%0.0%0.0%
 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy